shire plc (SHP:London)
Matthew W. Emmens
Former Non-Executive Chairman and Member of Nomination Committee, Shire plc
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 5 different industries.|
Mr. Matthew W. Emmens, also known as Matt, serves as Chief Executive Officer of Shire Pharmaceuticals Group plc. Mr. Emmens served as the Chief Executive Officer of Vertex Pharmaceuticals Incorporated from May 23, 2009 to February 1, 2012, and served as its President from February 2009 to February 1, 2012. Mr. Emmens served as the Chief Executive Officer of Shire plc from March 12, 2003 to June 18, 2008. He joined Shire in 2003 and was based in Darmstadt, Germany as ...
5 RiverwalkPhone: 353 1 429 7700
Dublin, Co. Dublin 24
Board Members Memberships*
Former Executive Director and Member of Science & Technology Committee
Former Director and Member of Audit Committee
Former Non-Executive Chairman and Member of Nomination Committee
Fairleigh Dickinson University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Richard F. Pops||Chairman of the Board and Chief Executive Officer|
|Jean-Jacques Bienaime MBA||Chief Executive Officer and Director|
BioMarin Pharmaceutical Inc.
|Leonard S. Schleifer M.D., Ph.D.||Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee|
Regeneron Pharmaceuticals, Inc.
|Rakesh Sachdev||Chief Executive Officer, President and Director|
|Bruce C. Cozadd||Co-Founder, Executive Chairman and Chief Executive Officer|
Jazz Pharmaceuticals Public Limited Company
|$771.2K||Compensation as of Fiscal Year 2013.|